Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Postoperative chemoradiotherapy is the recommended standard therapy for patients with locally advanced rectal cancer. In recent years, encouraging results with preoperative radiotherapy have been reported. We compared preoperative chemoradiotherapy with postoperative chemoradiotherapy for locally advanced rectal cancer. METHODS: We randomly assigned patients with clinical stage T3 or T4 or node-positive disease to receive either preoperative or postoperative chemoradiotherapy. The preoperative treatment consisted of 5040 cGy delivered in fractions of 180 cGy per day, five days per week, and fluorouracil, given in a 120-hour continuous intravenous infusion at a dose of 1000 mg per square meter of body-surface area per day during the first and fifth weeks of radiotherapy. Surgery was performed six weeks after the completion of chemoradiotherapy. One month after surgery, four five-day cycles of fluorouracil (500 mg per square meter per day) were given. Chemoradiotherapy was identical in the postoperative-treatment group, except for the delivery of a boost of 540 cGy. The primary end point was overall survival. RESULTS: Four hundred twenty-one patients were randomly assigned to receive preoperative chemoradiotherapy and 402 patients to receive postoperative chemoradiotherapy. The overall five-year survival rates were 76 percent and 74 percent, respectively (P=0.80). The five-year cumulative incidence of local relapse was 6 percent for patients assigned to preoperative chemoradiotherapy and 13 percent in the postoperative-treatment group (P=0.006). Grade 3 or 4 acute toxic effects occurred in 27 percent of the patients in the preoperative-treatment group, as compared with 40 percent of the patients in the postoperative-treatment group (P=0.001); the corresponding rates of long-term toxic effects were 14 percent and 24 percent, respectively (P=0.01). CONCLUSIONS: Preoperative chemoradiotherapy, as compared with postoperative chemoradiotherapy, improved local control and was associated with reduced toxicity but did not improve overall survival.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Among the patients in whom abdominoperineal resection (APR) was considered necessary at the time of enrollment, the percentage of patients in whom sphincter preservation was possible was significantly higher in the preoperative chemoradiotherapy group [119].”
From Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer (2018) · cites this paper as [119]
In the citing paper
“there was no significant difference in the 5-year survival rate”
From Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer (2018) · cites this paper as [119]
In the citing paper
“but the local recurrence rate and incidence of grade 3 or higher adverse events were significantly lower in the preoperative chemoradiotherapy group.”
From Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer (2018) · cites this paper as [119]
Citations
Cites
Statistical Methods in Cancer Research
Breslow, N. E. (1980) · Cited by 7,332
Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal Cancer
Kapiteijn, E., Marijnen, C. A. M., Nagtegaal, I. D., Putter, H., Steup, W. H., Wiggers, T., Rutten, H. J. T., Pahlman, L., Glimelius, B., van Krieken, J. H. J. M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010580 · Cited by 4,205
Improved Survival with Preoperative Radiotherapy in Resectable Rectal Cancer
(1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361402 · Cited by 2,517
Effective Surgical Adjuvant Therapy for High-Risk Rectal Carcinoma
Krook, J. E., Moertel, C. G., Gunderson, L. L., Wieand, H. S., Collins, R. T., Beart, R. W., Kubista, T. P., Poon, M. A., Meyers, W. C., Mailliard, J. A., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103143241101 · Cited by 1,879
Statistical methods in cancer research. Vol. 1. The analysis of case-control studies
(1983) · Food and Chemical Toxicology · doi:10.1016/0278-6915(83)90281-8 · Cited by 1,716
Prolongation of the Disease-Free Interval in Surgically Treated Rectal Carcinoma
Gastrointestinal Tumor Study Group (1985) · New England Journal of Medicine · doi:10.1056/nejm198506063122301 · Cited by 1,130
(2001) · The Lancet · doi:10.1016/s0140-6736(01)06409-1 · Cited by 870
Preoperative Radiotherapy for Resectable Rectal Cancer: A Meta-analysis
Cammà, C., Giunta, M., Fiorica, F., Pagliaro, L., Craxì, A., & Cottone, M. (2000) · JAMA · doi:10.1001/jama.284.8.1008 · Cited by 754
NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer
(1990) · JAMA · doi:10.1001/jama.264.11.1444 · Cited by 394
Hyams, D. M., Mamounas, E. P., Petrelli, N., Rockette, H., Jones, J., Wieand, S. H., Deutsch, M., Wickerham, L. D., Fisher, B., & Wolmark, N. (1997) · Diseases of the Colon & Rectum · doi:10.1007/bf02054976 · Cited by 360
Research works printed but not linked: 3
- Seegenschmiedt MH, 1993, Strahlenther Onkol, 169, 83
- Pichlmaier H, 1994, Chirurg, 65, 411
- Hermanek P. What can the pathologist tell the surgeon about rectal cancer resection? In: Scholefield JH, ed. Challenges in colorectal cancer. Oxford, England: Blackwell, 2000:81-90.
Cited by
Items 901–1,000 of 1,004
Lindebjerg, J., Spindler, K.-L. G., Pløen, J., & Jakobsen, A. K. M. (2008) · Colorectal Disease · doi:10.1111/j.1463-1318.2008.01599.x · Cited by 52
Pucciarelli, S., Bianco, P. D., Efficace, F., Toppan, P., Serpentini, S., Friso, M. L., Lonardi, S., Salvo, G. L. D., & Nitti, D. (2009) · Supportive Care in Cancer · doi:10.1007/s00520-009-0699-y · Cited by 64
“cases [5, 6]. However, using this approach, severe acute toxicity has been reported in up to 40% of cases [2–4, 7], long-term toxic effects from 14% to 27% [ 2 , 7], postoperative complications from 21% to 36% and anastomotic leak from 7% to 12% of cases [4, 8]. The effect of pCRT may have potential detrimental effect…”
BackgroundMacGregor, T. P., Maughan, T., & Sharma, R. A. (2012) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2012-200958 · Cited by 56
“It has been shown that patients with radiological T3/T4 tumours exhibiting a pCR to neoadjuvant chemoradiotherapy are at a low risk of local recurrence.(12) A small study (26 patients) looking at neoadjuvant chemoradiotherapy followed by local excision of the tumour for more advanced (T2/T3) distal rectal tumours with…”
BackgroundPolignano, F. M., Quyn, A. J., Pandanaboyana, S., Henderson, N., & Tait, I. S. (2012) · Surgical Endoscopy · doi:10.1007/s00464-012-2235-2 · Cited by 51
“In a recent, prospective, randomized, controlled trial, up to 50 % of patients did not undergo optimal treatment of their synchronous liver disease after rectal resection [20].”
BackgroundLocal recurrence after curative resection for rectal carcinoma: The role of surgical resection
Yun, J.-A., Huh, J. W., Kim, H. C., Park, Y. A., Cho, Y. B., Yun, S. H., Lee, W. Y., & Chun, H.-K. (2016) · Medicine · doi:10.1097/md.0000000000003942 · Cited by 62
Huang, C., Huang, M., Ma, C., Yeh, Y., Tsai, H., Huang, C., Huang, C., & Wang, J. (2017) · Radiation Oncology · doi:10.1186/s13014-017-0790-3 · Cited by 54
“Neoadjuvant CCRT is the standard of care in patients with locally advanced rectal cancer [6].”
BackgroundBisschop, K., van Dijk, T. H., Beukema, J. C., Jansen, R. L. H., Gelderblom, H. A. J., de Jong, K. P., Rutten, H. J. T., van de Velde, C. J. �., Wiggers, T., Havenga, K., et al. (2017) · Annals of Surgical Oncology · doi:10.1245/s10434-017-5897-0 · Cited by 54
“accomplished with neoadjuvant radiotherapy or chemoradiotherapy.(4,5) Long-course radiotherapy with concomitant 5-fluorouracil-based chemotherapy is the standard neoadjuvant regimen for locally advanced rectal cancer.”
BackgroundMethodEnkhbaatar, N.-E., Inoue, S., Yamamuro, H., Kawada, S., Miyaoka, M., Nakamura, N., Sadahiro, S., & Imai, Y. (2018) · Radiology · doi:10.1148/radiol.2018171804 · Cited by 51
Mège, D., Hain, É., Lakkis, Z., Maggiori, L., la Denise, J. P. À., & Panis, Y. H. (2018) · Colorectal Disease · doi:10.1111/codi.14238 · Cited by 51
Prognostic Impact of Perineural Invasion in Rectal Cancer After Neoadjuvant Chemoradiotherapy
Kim, C. H., Yeom, S., Lee, S. Y., Kim, H. R., Kim, Y. J., Lee, K., & Lee, J. H. (2018) · World Journal of Surgery · doi:10.1007/s00268-018-4774-8 · Cited by 53
Nahas, S. C., Nahas, C. S. R., Cama, G. M., de Azambuja, R. L., Horvat, N. D. S. M. R., Marques, C. F. S., de Menezes, M. R., Ribeiro, U., & Cecconello, I. (2019) · Abdominal Radiology · doi:10.1007/s00261-019-01894-8 · Cited by 51
Fei, F., Zhang, M., Li, B., Zhao, L.-Z., Wang, H., Liu, L., Li, Y., Ding, P., Gu, Y., Zhang, X., et al. (2019) · Journal of Oncology · doi:10.1155/2019/2316436 · Cited by 59
“For patients with LARC, nCRT has become the standard treatment strategy over the past decade [22] and has been recommended by major guidelines [14].”
Backgroundde Gooyer, J. M., Verstegen, M. G., Lam-Boer, J. ‘., Radema, S. A., Verhoeven, R. H. A., Verhoef, C. K., Schreinemakers, J. M. J., & de Wilt, J. H. W. (2019) · Digestive Surgery · doi:10.1159/000503446 · Cited by 57
CoA Synthase ( COASY ) Mediates Radiation Resistance via PI3K Signaling in Rectal Cancer
Ferrandon, S., DeVecchio, J., Duraes, L. C., Chouhan, H. S., Karagkounis, G., Davenport, J., Orloff, M., Liska, D., & Kalady, M. F. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-1161 · Cited by 56
“Neoadjuvant chemoradiation therapy (nCRT) followed by surgery decreases local recurrence (3,4) and is considered standard of care for locally advanced rectal cancer (5,6).”
BackgroundNahas, C. S. R., Akhurst, T., YEUNG, H. W. D., Riedel, E., Markowitz, A. J., Minsky, B. D., Paty, P. B., Weiser, M. R., Temple, L. K. F., Wong, W. D., et al. (2007) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9626-y · Cited by 51
“The following comments should be made: (1) All PET scan findings were evaluated in correlation to CT findings.”
BackgroundMarinello, F. G., Frasson, M., Báguena, G., Lorente, B. F., Cervantes, A. M. R., Roselló, S., Espí, A., & García‐Granero, E. (2015) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0000000000000349 · Cited by 56
Lee, D., Kim, C. H., Kim, Y. J., & Kim, H. R. (2015) · Oncology · doi:10.1159/000439279 · Cited by 50
PROSPECT Eligibility and Clinical Outcomes: Results From the Pan-Canadian Rectal Cancer Consortium
Bossé, D., Mercer, J., Raissouni, S. S., Dennis, K. E. B., Goodwin, R. A., Jiang, D., Powell, E. D., Kumar, A., Lee‐Ying, R. M., Hiller, J. A. P., et al. (2016) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2016.02.003 · Cited by 50
Nogueira, L., May, F. P., Yabroff, K. R., & Siegel, R. L. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.23.00539 · Cited by 51
“32,33 In our study, patients racialized as Black were more likely to not receive rectal cancer treatment in the correct order, consistent with fi ndings in the general population.”
ResultA critical review of the role of local excision in the treatment of early (T1 and T2) rectal tumors.
Heafner, T. A., & Glasgow, S. C. (2014) · PubMed · doi:10.3978/j.issn.2078-6891.2014.066 · Cited by 50
“Neoadjuvant chemoradiation has consistently demonstrated the ability to reduce local recurrence rates and downstage primary tumors in select patients with rectal cancers (18,19).”
BackgroundContemporary perioperative care strategies
Adamina, M., Gié, O., Demartines, N., & Ris, F. (2012) · British journal of surgery · doi:10.1002/bjs.8990 · Cited by 51
Determinants of survival following pelvic exenteration for primary rectal cancer
Radwan, R. W., Jones, H. G., Rawat, N., Davies, M., Evans, M. D., Harris, D. A., Beynon, J., Swansea Pelvic Oncology Group, McGregor, A. D., Morgan, A. R., et al. (2015) · British journal of surgery · doi:10.1002/bjs.9841 · Cited by 50
Salazar, R., Capdevila, J., Laquente, B., Manzano, J. L., Pericay, C., Villacampa, M. M., López, C., Losa, F., Safont, M. J., Gómez, A., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1053-z · Cited by 55
“The objective of the current study was to evaluate the addition of bevacizumab (BEV) to preoperative capecitabine (CAP)-based CRT in LARC, and to explore biomarkers for downstaging.”
BackgroundInfluentialEngels, B., Tournel, K., Everaert, H., Hoorens, A., Sermeus, A. B. L., Christian, N., Storme, G. A., Verellen, D., & Ridder, M. D. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.05.068 · Cited by 52
von Bernstorff, W., Glitsch, A., Schreiber, A., Partecke, L. I., & Heidecke, C.-D. (2009) · International Journal of Colorectal Disease · doi:10.1007/s00384-009-0673-7 · Cited by 51
“[13]).”
Gehoff, A., Basten, O., Sprenger, T., Conradi, L., Bismarck, C., Bandorski, D., Merkelbach‐Bruse, S., Schneider‐Stock, R., Stoehr, R., Wirtz, R. M., et al. (2012) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31823fa35b · Cited by 51
“Block number Per case: mean (range) 47 (119-213) NA 27 (22-59) NA For mesorectal LN compartment mean (range) NA 22 (4-44) 10 (3-20) NA Technical equipment Instrumentation Conventional Approximately h850 Conventional Conventional”
BackgroundSelf-citationGrade, M., Wolff, H. A., Gaedcke, J., & Ghadimi, Β. M. (2012) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-012-0929-5 · Cited by 54
“In this respect, the TransValid-KFO179/GRCSG-Trials (TransValid A, TransValid B) are the first biomarkerdriven clinical trials for patients with rectal cancer (Fig.”
BackgroundMethodInfluentialMultidisciplinary Discussion and Management of Rectal Cancer: A Population‐based Study
Swellengrebel, H. A. M., Peters, E. G., Cats, A., Visser, O. J., Blaauwgeers, H. G. T., Verwaal, V. J., van Velthuysen, M. F., Cense, H. A., Bruin, S., & Marijnen, C. A. M. (2011) · World Journal of Surgery · doi:10.1007/s00268-011-1181-9 · Cited by 54
MRI-defined height of rectal tumours
Keller, D. S., Paspulati, R. M., Kjellmo, Å., Rokseth, K. M., Bankwitz, B., Wibe, A., & Delaney, C. P. (2013) · British journal of surgery · doi:10.1002/bjs.9355 · Cited by 50
Guo, S., Reddy, C. A., Kolar, M. D., Woody, N. M., Mahadevan, A., Deibel, F. C., Dietz, D. W., Remzi, F. H., & Suh, J. H. (2012) · Radiation Oncology · doi:10.1186/1748-717x-7-110 · Cited by 54
“Many locally advanced lesions can be rendered resectable with preoperative chemotherapy and radiation, and modern recurrence rates range from 6-10 % after neoadjuvant therapy [1-4].”
BackgroundMartens, M. H., van Heeswijk, M. M., van den Broek, J. J., Rao, S., Vandecaveye, V., Vliegen, R. F. A., Schreurs, W. H., Beets, G. L., Lambregts, D. M. J., & Beets‐Tan, R. G. H. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.09.008 · Cited by 52
“The aim of the present study was 3-fold: (1) to systematically review the available literature on the value of tumor size/volume measurements on MRI (using routine T2-weighted sequences) for tumor response prediction and assessment in patients with rectal cancer undergoing preoperative CRT; (2) to prospectively valida…”
BackgroundMethodInfluentialToiyama, Y., Inoue, Y., Kawamura, M., Kawamoto, A., Okugawa, Y., Hiro, J., Saigusa, S., Tanaka, K., Mohri, Y., & Kusunoki, M. (2015) · International Surgery · doi:10.9738/intsurg-d-13-00178.1 · Cited by 50
“Preoperative chemoradiotherapy (CRT) and total mesorectal excision for the management of locally advanced rectal cancer (LARC) have significantly decreased local recurrence rates and improved sphincter preservation and patient survival.(1,2) However, distant recurrence remains”
BackgroundSaigusa, S., Toiyama, Y., Tanaka, K., Inoue, Y., Mori, K., Ide, S., Imaoka, H., Kawamura, M., Mohri, Y., & Kusunoki, M. (2016) · International Journal of Clinical Oncology · doi:10.1007/s10147-016-0962-4 · Cited by 52
Importance of surgical margins in rectal cancer
Krishnamurty, D. M., & Wise, P. E. (2016) · Journal of Surgical Oncology · doi:10.1002/jso.24136 · Cited by 50
Hall, M. D., Schultheiss, T. E., Smith, D. D., Fakih, M., Wong, J. Y. C., & Chen, Y. (2016) · Acta Oncologica · doi:10.1080/0284186x.2016.1235797 · Cited by 53
Creavin, B., Kelly, M. E., Ryan, É. J., & Winter, D. C. (2017) · British journal of surgery · doi:10.1002/bjs.10664 · Cited by 54
Jang, J. H., Kim, H. C., Huh, J. W., Park, Y. A., Cho, Y. B., Yun, S. H., Lee, W. Y., Yu, J. I., Park, H. C., Park, Y. S., et al. (2017) · Annals of Surgery · doi:10.1097/sla.0000000000002582 · Cited by 50
Corradini, S., Krug, D. A., Meattini, I., Matuschek, C., Bölke, E., Francolini, G., Baumann, R., Figlia, V., Pazos, M., Tonetto, F., et al. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.06.003 · Cited by 59
Mezhir, J. J., Smith, K. D., Fichera, A., Hart, J. A. L., Posner, M. C., & Hurst, R. D. (2005) · Surgery · doi:10.1016/j.surg.2005.06.048 · Cited by 50
Freedman, G. M., Meropol, N. J., Sigurdson, E. R., Hoffman, J., Callahan, E., Price, R., Cheng, J. D., Cohen, S. M., Lewis, N. L., Bruner, D. W., et al. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.11.017 · Cited by 50
Smith, F. M., Reynolds, J. V., Kay, E. W., Crotty, P. L., Murphy, J. O., Hollywood, D. P., Gaffney, E. F., Stephens, R. B., & Kennedy, M. J. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.07.961 · Cited by 50
Zlobec, I., Steele, R. J., Nigam, N., & Compton, C. C. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2587 · Cited by 50
Does chronomodulated radiotherapy improve pathological response in locally advanced rectal cancer?
Squire, T., Buchanan, G., Rangiah, D. S., Davis, I. P., Yip, D., Chua, Y. J., Rich, T. A., & Elsaleh, H. (2017) · Chronobiology International · doi:10.1080/07420528.2017.1301462 · Cited by 50
“The German Rectal Cancer Study Group conducted the CAO/ARO/AIO-94 trial comparing preoperative versus postoperative chemoradiotherapy in locally advanced rectal cancer which found that neoadjuvant treatment was associated with improved local control rates, fewer toxicities and improved sphincter preservation rates (Sa…”
BackgroundMethodSánchez-Alcoholado, L., Laborda-Illanes, A., Otero, A., Ordóñez, R., González-González, A., Plaza-Andrades, I., Ramos-Molina, B., Gómez-Millán, J., & Queipo-Ortuño, M. I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179549 · Cited by 49
“Preoperative radiochemotherapy (RCT) followed by surgery has become the standard treatment for patients with CRC [8,9].”
BackgroundMolecular targeted treatment and radiation therapy for rectal cancer
Marquardt, F., Rödel, F., Capalbo, G., Weiß, C., & Rödel, C. M. (2009) · Strahlentherapie und Onkologie · doi:10.1007/s00066-009-1936-5 · Cited by 53
“Preoperative radiotherapy (RT) with or without concurrent chemotherapy or hyperthermia and total mesorectal excision surgery have optimized local control rates in rectal cancer patients [6, 15, 20, 31, 37, 40 ].”
BackgroundSelf-citationHaynes, A. B., You, Y. N., Hu, C., Eng, C., Kopetz, S., Rodríguez-Bigas, M. A., Skibber, J. M., Cantor, S. B., & Chang, G. J. (2014) · Cancer · doi:10.1002/cncr.28545 · Cited by 51
“Multiple clinical trials have demonstrated a benefit to local control using this approach with a potential for survival benefit as well.(3,4) Although this course of therapy often results in substantial tumor regression, current recommendations are based on clinical staging, not post-therapy pathologic staging.”
BackgroundParekh, A., Truong, M. T., Pashtan, I. M., Qureshi, M. M., Martin, N. E., Nawaz, O., Cerda, S. R., Willins, J., Hartshorn, K. L., & Kachnic, L. A. (2013) · Europe PMC (PubMed Central) · Cited by 51
Tumor response assessment in locally advanced colon cancer after neoadjuvant chemotherapy.
Arredondo, J., González, I., Baixauli, J., Martínez, P., Rodríguez, J., Pastor, C., Ribelles, M. J., Sola, J. J., & Hernández-Lizoáin, J. L. (2014) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2078-6891.2014.006 · Cited by 49
“Several recent trials have been developed in order to assess the role of neoadjuvant chemotherapy in LACC (3-5), resembling its use in other locally advanced tumors (6,7).”
BackgroundPastor, C., Subtil, J., Sola, J. J., Baixauli, J., Beorlegui, C., Arbea, L., Aristu, J., & Hernández-Lizoáin, J. L. (2011) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0b013e31821c4a60 · Cited by 50
Weiß, C., Arnold, D., Dellas, K., Liersch, T., Hipp, M., Fietkau, R., Sauer, R., Hinke, A., & Rödel, C. M. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.07.1718 · Cited by 51
Self-citationde Campos‐Lobato, L. F., Stocchi, L., Moreira, A. D. L., Kalady, M. F., Geisler, D. P., Dietz, D., Lavery, I. C., Remzi, F. H., & Fazio, V. W. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-0924-4 · Cited by 51
“This approach results in reduced toxicity, within the bowel and overall, and has been reported to be associated with improved local control when compared with postoperative chemoradiation.(3)”
ResultBorg, C., André, T., Mantion, G., Boudghene, F. P., Mornex, F., Maingon, P., Adenis, A., Azria, D., Piutti, M., Morsli, O., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu377 · Cited by 51
“Distant metastases occurred in >30% of patients [2-4].”
BackgroundFuture Directions for Monitoring Treatment Response in Colorectal Cancer
Walker, A. S., Zwintscher, N. P., Johnson, E. K., Maykel, J. A., Stojadinovic, A., Nissan, A., Avital, I., Brücher, B. L. D. M., & Steele, S. R. (2014) · Journal of Cancer · doi:10.7150/jca.7809 · Cited by 53
Cho, S. H., Kim, G. C., Jang, Y., Ryeom, H., Kim, H. J., Shin, K. M., Park, J. S., Choi, G., & Kim, S. H. (2014) · Acta Radiologica · doi:10.1177/0284185114550193 · Cited by 49
“Approximately 10–20% of patients achieved a pathologic complete response (pCR) after preoperative CRT (1,5,6).”
BackgroundRisk-Adjusted Pathologic Margin Positivity Rate As a Quality Indicator in Rectal Cancer Surgery
Massarweh, N. N., Hu, C., You, Y. N., Bednarski, B. K., Rodríguez-Bigas, M. A., Skibber, J. M., Cantor, S. B., Cormier, J. N., Feig, B. W., & Chang, G. J. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.5334 · Cited by 49
Habr‐Gama, A., Perez, R. O., Julião, G. P. S., Proscurshim, I., Fernandez, L. M., Figueiredo, M. N., Gama-Rodrigues, J. J., & Buchpiguel, C. A. (2016) · Radiation Oncology · doi:10.1186/s13014-016-0598-6 · Cited by 49
“In addition to the potential benefits in improved local disease control, neoadjuvant CRT may result in significant tumor downsizing and tumor downstaging [2].”
Lin, J., Peng, J., Qdaisat, A. Z., Li, L., Chen, G., Lu, Z., Wu, X., Gao, Y., Zeng, Z., Ding, P., et al. (2016) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-016-2225-1 · Cited by 51
Lee, M. A., Cho, S. H., Seo, A. N., Kim, H. J., Shin, K. M., Kim, S. H., & Choi, G. (2017) · American Journal of Roentgenology · doi:10.2214/ajr.16.17242 · Cited by 49
Park, S. E., Hwang, I. G., Choi, C. H., Kang, H., Kim, B. G., Park, B. K., Cha, S. J., Jang, J.-S., & Choi, J. H. (2018) · Medicine · doi:10.1097/md.0000000000013363 · Cited by 51
“Although 5-year local control was significantly improved in preoperative treatment arm in that German trial, overall survival was unchanged.([1]) However, that study did not include many older patients, making it difficult to apply it as a standard therapy in older patients.”
BackgroundResultInfluentialIppolito, E., Mertens, I., Haustermans, K. M., Gambacorta, M. A., Pasini, D., & Valentini, V. (2008) · Acta Oncologica · doi:10.1080/02841860802256459 · Cited by 55
“Also in patients with low-seated tumours higher doses could improve the tumour downsizing improving the rate of sphincter preservation [10,11], even if this benefit is still controversial [12].”
BackgroundDenoya, P. I., Wang, H.-W., Sands, D. R., Nogueras, J. J., Weiss, E. G., & Wexner, S. D. (2009) · Surgical Endoscopy · doi:10.1007/s00464-009-0702-1 · Cited by 49
“An additional benefit of neoadjuvant therapy was the significant downstaging of the tumor, which allowed for more sphincter-preserving resections by preoperatively shrinking the tumor [7].”
BackgroundSaif, M. W., Hashmi, S., Zelterman, D. A., Almhanna, K., & Kim, R. D. (2007) · International Journal of Colorectal Disease · doi:10.1007/s00384-007-0382-z · Cited by 49
“In patients with locally advanced rectal cancer (T3, T4, or N1), neoadjuvant chemoradiation has now become a standard based on German Rectal Cancer Study [2].”
BackgroundKrause, M., Prager, J., Zhou, X., Yaromina, A., Dörfler, A., Eicheler, W., & Baumann, M. A. (2007) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2007.04.014 · Cited by 56
“due to vascular damage and hypoxia [29,38,39], these findings warrant further investigations.”
BackgroundGunderson, L. L., Callister, M. D., Marschke, R. F., Young‐Fadok, T. M., Heppell, J. P., & Efron, J. E. (2008) · PubMed · Cited by 54
Lim, S., Yu, C. S., Kim, C. W., Yoon, Y. S., Park, S. H., Kim, T. W., Kim, J. H., & Kim, J. C. (2013) · International Journal of Colorectal Disease · doi:10.1007/s00384-013-1761-2 · Cited by 48
“Since the German group demonstrated the value of CRT for decreasing local recurrence [2], preoperative CRT followed by TME has been the standard treatment for patients with locally advanced rectal cancer.”
BackgroundMethodDynamic modulated brachytherapy (DMBT) for rectal cancer
Webster, M. J., Dević, S., Vuong, T., Han, D. Y., Park, J. C., Scanderbeg, D. J., Lawson, J. D., Song, B., Watkins, W. T., Pawlicki, T. A., et al. (2012) · Medical Physics · doi:10.1118/1.4769416 · Cited by 48
Fiorica, F., Cartei, F., Licata, A., Enea, M., Ursino, S., Colosimo, C., & Cammà, C. (2010) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2010.03.002 · Cited by 55
Watanabe, T., Kobunai, T., Akiyoshi, T., Matsuda, K., Ishihara, S., & Nozawa, K. (2013) · Diseases of the Colon & Rectum · doi:10.1097/01.dcr.0000437688.33795.9d · Cited by 48
“Preoperative chemoradiotherapy has been widely used as a major treatment modality to improve local control of the disease and to improve survival.(1,2) however, the response to chemoradiotherapy differs among individual tumors.”
MethodMilestones in the Use of Combined-Modality Radiation Therapy and Chemotherapy
Lawrence, T. S., Haffty, B. G., & Harris, J. R. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.2281 · Cited by 54
“therapy, thereby establishing preoperative CMT as the standard of care.(52)”
MethodJo, P., Jung, K., Grade, M., Conradi, L., Wolff, H. A., Kitz, J., Becker, H., Rüschoff, J., Hartmann, A., Beißbarth, T., et al. (2011) · Surgery · doi:10.1016/j.surg.2011.08.013 · Cited by 49
Lee, J. H., Jang, H. S., Kim, J.-G., Cho, H. M., Shim, B. Y., Oh, S. T., Yoon, S., Kim, Y., Choi, B. O., & Kim, S. H. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-2062-z · Cited by 50
“In recent years, the local recurrence rate has been lowered to 7–13% with the advent of TME.(2,4) Lymphovascular invasion (LVI) is widely recognized as an independent prognostic factor for malignancies, such as endometrial, bladder, and colon cancers.”
BackgroundInfluentialDhadda, A. S., Zaitoun, A. M., & Bessell, E. M. (2008) · Clinical Oncology · doi:10.1016/j.clon.2008.10.011 · Cited by 53
Choi, C. H., Kim, W. D., Lee, S. J., & Park, W. (2012) · Radiation Oncology Journal · doi:10.3857/roj.2012.30.3.99 · Cited by 48
“A prospective randomized trial confirmed the superiority of preoperative over adjuvant CRT in terms of local control and toxicity [5].”
BackgroundReview on adjuvant chemotherapy for rectal cancer – why do treatment guidelines differ so much?
Poulsen, L. Ø., Qvortrup, C., Pfeiffer, P., Yilmaz, M., Falkmer, S., & Sørbye, H. (2015) · Acta Oncologica · doi:10.3109/0284186x.2014.993768 · Cited by 57
Peng, J., Shi, D., Goodman, K. A., Goldstein, D. P., Xiao, C., Guan, Z., & Cai, S. (2011) · Radiation Oncology · doi:10.1186/1748-717x-6-93 · Cited by 50
“Radiotherapy or chemoradiotherapy was introduced into this field due to the reduction of local recurrence for locally advanced rectal cancer[1,12].”
BackgroundExtended Lymphadenectomy in Colon Cancer is Crucial
Kessler, H. P., & Hohenberger, W. (2013) · World Journal of Surgery · doi:10.1007/s00268-013-2130-6 · Cited by 48
“[12–15].”
Self-citationOncological and Functional Outcomes of Intersphincteric Resection for Low Rectal Cancer
Kuo, L., Hung, C., Wu, C., Wang, W., Tam, K., Liang, H., Chang, Y., & Wei, P. (2011) · Journal of Surgical Research · doi:10.1016/j.jss.2011.05.018 · Cited by 48
Roeder, F., Treiber, M., Oertel, S., Dinkel, J., Timke, C., Funk, A., Schüler, H. I. G., Bischof, M., Weitz, J., Harms, W., et al. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.11.039 · Cited by 48
Chong, I. Y.-S., Hawkins, M., Hansen, V. N., Thomas, K., McNair, H. A., O’Neill, B., Aitken, A., & Tait, D. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.04.060 · Cited by 53
Cai, X., Wu, H., Peng, J., Zhu, J. Y., Cai, S., Cai, G., & Zhang, Z. (2013) · Radiation Oncology · doi:10.1186/1748-717x-8-86 · Cited by 54
“multidisciplinary treatment in older patients, and treatment deviation is higher in elderly patients than younger patients [8-10].”
BackgroundThe role of radiotherapy in multimodal treatment of pancreatic carcinoma
Brunner, T. B., & Scott-Brown, M. (2010) · Radiation Oncology · doi:10.1186/1748-717x-5-64 · Cited by 49
“Neoadjuvant chemoradiotherapy resulted in tumour regression causing a higher rate of R0-resections, improved local control and lower long term toxicity compared with post-operative chemoradiotherapy [33].”
BackgroundMagnetic resonance imaging and endorectal ultrasound for diagnosis of rectal lesions
Burdan, F., Sudoł‐Szopińska, I., Starosławska, E., Kołodziejczak, M., Klepacz, R., Mocarska, A., Caban, M. A., Żelazowska-Cieślińska, I., & Szumiło, J. (2015) · European journal of medical research · doi:10.1186/s40001-014-0078-0 · Cited by 48
“Moreover, patients with preoperative neoadjuvant therapy had a substantially lower rate of local recurrence compared with those who received similar postoperative treatment [43].”
ResultThe Importance of a Minimal Tumor-Free Resection Margin in Locally Recurrent Rectal Cancer
Alberda, W. J., Verhoef, C. K., Schipper, M. E. I., Nuyttens, J. J. M. E., Rothbarth, J., de Wilt, J. H. W., & Burger, J. W. A. (2015) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0000000000000388 · Cited by 50
Young Age Increases Risk of Lymph Node Positivity in Early-Stage Rectal Cancer
Meyer, J. E., Cohen, S. J., Ruth, K. J., Sigurdson, E. R., & Hall, M. J. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv284 · Cited by 48
Loree, J. M., Javaheri, K. R., Lefresne, S., Speers, C. H., Ruan, J. Y., Chang, J. T., Brown, C. J., Kennecke, H. F., Olson, R. A., & Cheung, W. Y. (2016) · The Journal of Rural Health · doi:10.1111/jrh.12219 · Cited by 48
“We attempted to assess quality by comparing the number of patients receiving pre- versus postoperative RT after guidelines were amended to reflect this important change in practice, but we did not find any differences in treatment timing.(26) In a companion study, our group is also assessing the impact of community si…”
MethodTerranova-Barberio, M., Pecori, B., Roca, M. S., Imbimbo, S., Bruzzese, F., Leone, A., Muto, P., Delrio, P., Avallone, A., Budillon, A., et al. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0647-5 · Cited by 52
“Preoperative fluoropyrimidine-based chemo-radiotherapy followed by surgery is the preferred treatment option for patients with stages II and III rectal disease [4, 5].”
Monitoring Therapy Efficiency in Cancer through Extracellular Vesicles
Stevic, I., Buescher, G., & Ricklefs, F. L. (2020) · Cells · doi:10.3390/cells9010130 · Cited by 54
“At present, surgical resection combined with adjuvant or neoadjuvant chemo-radiation are available therapy options [55].”
BackgroundOptimising functional outcomes in rectal cancer surgery
Nocera, F. D., Angehrn, F., von Flüe, M., & Steinemann, D. C. (2020) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-020-01937-5 · Cited by 55
Wolff, H. A., Conradi, L., Beißbarth, T., Leha, A., Hohenberger, W., Merkel, S., Fietkau, R., Raab, H.-R., Tschmelitsch, J., Hess, C. F., et al. (2013) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2013.05.009 · Cited by 50
“This study represents a clinical add-on evaluation of the multicentric, open-label, randomizedCAO/ARO/AIO-94phase III trial conducted by the GRCSG [2].”
BackgroundMethodInfluentialSelf-citationPoon, E., Reniers, B., Dević, S., Vuong, T., & Verhaegen, F. (2006) · Medical Physics · doi:10.1118/1.2364054 · Cited by 54
Crane, C. H., Varadhachary, G., Wolff, R. A., Pisters, P. W. T., & Evans, D. B. (2006) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2005.11.005 · Cited by 48
Image-guided Radiotherapy for Rectal Cancer — A Systematic Review
Gwynne, S., Webster, R., Adams, R., Mukherjee, S., Coles, B., & Staffurth, J. (2011) · Clinical Oncology · doi:10.1016/j.clon.2011.07.012 · Cited by 51
Berman, A. T., Both, S., Sharkoski, T., Goldrath, K., Tochner, Z. A., Apisarnthanarax, S., Metz, J. M., & Plastaras, J. P. (2014) · International Journal of Particle Therapy · doi:10.14338/ijpt.13-00002.1 · Cited by 48
The Multimodal Management of Locally Advanced Rectal Cancer: Making Sense of the New Data
Zwart, W. H., Hotca, A. E., Hospers, G. A. P., Goodman, K. A., & García‐Aguilar, J. (2022) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_351411 · Cited by 58
Donnelly, M., Ryan, O. K., Ryan, É. J., Creavin, B., O’Reilly, M., McDermott, R., Kennelly, R. P., Hanly, A. M., Martin, S., & Winter, D. C. (2023) · British journal of surgery · doi:10.1093/bjs/znad177 · Cited by 52
Kim, C. W., Yu, C. S., Yang, S., Kim, K. H., Yoon, Y. S., Yoon, S. N., Lim, S., & Kim, J. C. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1740-1 · Cited by 47
Robertson, J. M., Söhn, M., & Yan, D. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.04.048 · Cited by 48
Glimelius, B. L. G. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00050 · Cited by 52
Controversies in the oncosurgical management of liver limited stage IV colorectal cancer
Jones, R. P., Stättner, S., Sutton, P. A., Dunne, D. F. J., McWhirter, D., Fenwick, S. W., Malik, H. M. A., & Poston, G. J. (2014) · Surgical Oncology · doi:10.1016/j.suronc.2014.02.002 · Cited by 49
“chemotherapy after surgery for the primary tumour [74].”
BackgroundCai, G. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i33.5520 · Cited by 47
Metadata
- Authors
- Sauer, R., Becker, H., Hohenberger, W., Rödel, C., Wittekind, C., Fietkau, R., Martus, P., Tschmelitsch, J., Hager, E., Hess, C. F., Karstens, J.-H., Liersch, T., Schmidberger, H., & Raab, R.
- Affiliations
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Leipzig University (DE)
- University of Rostock (DE)
- Charité – Universitätsmedizin Berlin (DE)
- Hospital of the Brothers of St. John of God (AT)
- Klinikum Klagenfurt (AT)
- University of Göttingen (DE)
- Medizinische Hochschule Hannover (DE)
- Klinikum Oldenburg (DE)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-10-21
- Volume
- 351
- Issue
- 17
- Pages
- 1731-1740
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2125452425
- Cited by
- 6,050
- References
- 19
- Citations by year
- 2026: 178 · 2025: 205 · 2024: 232 · 2023: 275 · 2022: 310 · 2021: 324 · 2020: 322 · 2019: 321 · 2018: 305 · 2017: 298 · 2016: 291 · 2015: 348 · 2014: 340 · 2013: 333 · 2012: 346
- FWCI
- 82.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- GRO (submittedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Colorectal Cancer Surgical Treatments
- Health Sciences › Medicine › Surgery › Colorectal and Anal Carcinomas
- Health Sciences › Medicine › Obstetrics and Gynecology › Endometrial and Cervical Cancer Treatments
- Keywords
- rectal cancer, locally advanced rectal cancer, neoadjuvant chemoradiotherapy, postoperative chemoradiotherapy, neoadjuvant therapy, adjuvant therapy, 5-fluorouracil, boost radiotherapy, local recurrence, overall survival, treatment toxicity
- MeSH terms
- Adult, Aged, Antineoplastic Agents, Combined Modality Therapy, Female, Fluorouracil, Follow-Up Studies, Humans, Male, Middle Aged, Neoplasm Recurrence, Local, Neoplasm Staging, Postoperative Care, Postoperative Complications, Preoperative Care, Quality Control, Radiotherapy, Rectal Neoplasms, Incidence, Proportional Hazards Models, Survival Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.